Amy Weinfeld Schulman

Last updated

Amy Weinfeld Schulman is an American healthcare biotech venture capitalist, trained as a lawyer, who serves as a managing partner at Polaris Partners. [1] [2] [3] She focuses on investing in healthcare companies and early-stage biotech start-ups. [2] [4] She also chairs the Board of Directors for Alnylam Pharmaceuticals (NASDAQ: ALNY) [5] and ByHeart, [6] [7] and represents Polaris as a director for Kallyope, Thirty Madison, QurAlis, and Larkspur. [8] She also practiced as a lawyer.

Contents

Early life

Both her parents practiced law and were the first in their families to attend college. [9] Her mother, Ann, graduated at the age of 45 and her father after he had served in the US Coast Guards. [9]

Education

She is a Phi Beta Kappa graduate of Wesleyan University, where she received a joint degree in philosophy and English, and she obtained her J.D. from Yale Law School. [2] [4] [10]

Career

Schulman currently serves as a managing partner at Polaris Partners, which focuses on investing in healthcare companies and early-stage biotech start-ups. [11] [12] She also co-founded the Polaris Innovation Fund, which she has managed since its inception in 2017. [13] [2] She serves as chair of the Board of Directors of Alnylam Pharmaceuticals (NASDAQ: ALNY) and as chair of the Board of Directors of ByHeart. [14] [15] She also represents Polaris as a director on various boards, including Thirty Madison, QurAlis, and Larkspur. [2] [8] [16]

Before joining Polaris in 2014, Amy held various roles at Pfizer, beginning with general counsel and moving to the business side as president of Pfizer Nutrition and president of Pfizer Consumer Healthcare. [11] Initially serving as the general counsel, she later transitioned to the business side, [4] becoming the president of both Pfizer Nutrition and Pfizer Consumer Healthcare. [17] [18] Prior to her tenure at Pfizer, she practiced law as a partner at DLA Piper and began her career in litigation at Cleary Gottlieb Steen & Hamilton in 1991. [19] [20]

Philanthropy

Amy is active in philanthropic circles and also serves on the Boards of Action Against Hunger, Mount Sinai Hospital (where she co-chairs the Innovations Committee), and the California Institute of Technology. [21] [2] She is a member of Singapore’s Health and Biomedical Sciences International Advisory Council and the LifeSci NYC Advisory Council. [2] [1] [8]

Recognition

Amy has received numerous awards, including the Margaret Brent Women Lawyers of Achievement Award, Scientific American’s Worldview 100 List, Fierce Biotech’s Top 15 Women in Biotech, and Fortune Magazine’s 50 Most Powerful Women in Business. [22] [23] [1]

Personal life

Schulman is married to David Nachman, and together, they have three children: Ezra, Gideon, and Rafael. Amy and David reside in Brooklyn, New York. [9] [24]

Related Research Articles

<span class="mw-page-title-main">Evercore</span> American financial services company

Evercore Inc., formerly known as Evercore Partners, is a global independent investment banking advisory firm founded in 1995 by Roger Altman, David Offensend, and Austin Beutner. The firm has advised on over $4.7 trillion of merger, acquisition, and restructuring transactions since its founding. Evercore is widely considered one of the most prestigious and elite investment banking advisory firms.

Jeffrey B. Kindler is an American healthcare executive and private investor. He served as chairman and CEO of the pharmaceutical company Pfizer from 2006 to 2010. Kindler has later served as CEO of Centrexion Inc., and chairman of the GLG Institute.

<span class="mw-page-title-main">Suzanne Nora Johnson</span> American corporate lawyer and executive

Suzanne Nora Johnson is an American corporate lawyer and executive. Until 2007, she was vice chairman of Goldman Sachs, chair of the Global Markets Institute, head of the firm's Global Investment Research Division, and a member of the firm's management committee.

Roel Clark Campos is an American business lawyer. He served as Securities and Exchange Commissioner between 2002 and 2007. He is now a partner with the law firm Hughes Hubbard & Reed LLP.

Polaris Partners is a venture capital firm active in the field of healthcare and biotechnology companies. The company has offices in Boston, Massachusetts, New York, NY and San Francisco, California.

<span class="mw-page-title-main">Margaret Hamburg</span> American public health administrator (born 1955)

Margaret Ann "Peggy" Hamburg is an American physician and public health administrator, who is serving as the chair of the board of the American Association for the Advancement of Science (AAAS) and co-chair of the InterAcademy Partnership (IAP). She served as the 21st Commissioner of the U.S. Food and Drug Administration from May 2009 to April 2015.

<span class="mw-page-title-main">Sue Desmond-Hellmann</span> American oncologist, academic, and nonprofit administrator (born 1958)

Sue Desmond-Hellmann is an American oncologist and biotechnology leader who served as the Chief Executive Officer of the Bill & Melinda Gates Foundation from 2014 to 2020. In March 2024 she was elected as a board member of OpenAI. She was previously Chancellor of the University of California, San Francisco (UCSF), the first woman to hold the position, and Arthur and Toni Rembe Rock Distinguished Professor, and before that president of product development at Genentech, where she played a role in the development of the first gene-targeted cancer drugs, Avastin and Herceptin.

<span class="mw-page-title-main">Heather Podesta</span> American lawyer and lobbyist

Heather Miller Podesta is an American lawyer and lobbyist based in Washington, D.C. She is also a patron of contemporary art.

<span class="mw-page-title-main">Christopher Nixon Cox</span> American lawyer

Christopher Nixon Cox is an American lawyer based in New York. He is the son of Tricia Nixon Cox and Edward F. Cox, and grandson of President Richard Nixon and First Lady Pat Nixon. Cox is the CEO of Lightswitch Capital, a private equity fund investing in biotech companies.

John Bernkopf Frank is the Vice Chairman of Oaktree Capital Management, having previously served as Managing Principal.

Arie S. Belldegrun, FACS, is an Israeli-American urologic oncologist, billionaire businessman and investor.

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.

<span class="mw-page-title-main">Arbutus Biopharma</span> Canadian Bio Tech Company

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.

David Edmund Ian Pyott CBE was the CEO of Allergan, a pharmaceutical company from 1998 to 2015, when Allergan was acquired by Actavis. In 2014 he was one of the 25 highest-paid CEOs in the United States.

Elizabeth Odilile Ofili is a Nigerian-American physician and cardiology researcher. She was the first woman to become president of the Association of Black Cardiologists.

Roivant Sciences Ltd. is a healthcare company focused on applying technology to drug development and building subsidiary biotech and healthcare technology companies. It was founded in 2014 by Vivek Ramaswamy.

Sheppard, Mullin, Richter & Hampton LLP, often abbreviated as Sheppard Mullin, is an international law firm headquartered in Los Angeles, California. The firm has over 1,000 attorneys located in North America, Europe, and Asia. Founded in 1927, the firm includes 10 major practice areas ranging from Antitrust to Tax, and also industry-focused teams such as Entertainment, Healthcare, and Privacy & Security.

<span class="mw-page-title-main">William Rastetter</span> American scientist, entrepreneur and venture capitalist

William H.Rastetter, a scientist, entrepreneur and venture capitalist, is the chair of Neurocrine Biosciences, of Fate Therapeutics, and of Daré Bioscience, Inc. in San Diego, California. He is a founding board member and investor in GRAIL, Inc. in Menlo Park, California, and served for a period as the company's interim CEO (2017) and chair (2017-2018). Rastetter is also a director of Regulus Therapeutics and Entos, Inc.. He was a partner in the venture firm Venrock (2006-2013), and a trustee at Caltech (2015-2018). He has served as a director (1998-2016) and as chair of Illumina (2005-2016). He advised SVB Leerink (2014-2019) and currently advises Illumina Ventures.

John Maraganore is an American scientist, entrepreneur, and life sciences industry leader.

Helene Lois Kaplan was an American lawyer and nonprofit executive. She was of counsel at Skadden, Arps, Slate, Meagher & Flom and was the first person to serve as two-time Chairman of the Carnegie Corporation of New York.

References

  1. 1 2 3 "Amy Schulman | Polaris Partners" . Retrieved 2024-03-22.
  2. 1 2 3 4 5 6 7 "Ms. Amy Schulman - Board of Trustees". board.caltech.edu. Retrieved 2024-03-22.
  3. ↑ "Amy Schulman Elected as New Caltech Trustee". California Institute of Technology. 2023-09-13. Retrieved 2024-03-22.
  4. 1 2 3 "Amy Schulman '89 | Yale Law School". law.yale.edu. Retrieved 2024-03-22.
  5. ↑ "Alnylam Elects Amy Schulman to its Board of Directors". fiercepharma.com.
  6. ↑ ByHeart. "ByHeart Appoints Amy Schulman as Chair of the Board of Directors, Further Solidifying its Position as a Leader in the Infant Nutrition Category". www.prnewswire.com (Press release). Retrieved 2024-03-22.
  7. ↑ "ByHeart adds Amy Schulman and Hemi Zucker to Board along with raising $70m Series A financing led by Polaris Partners, OCV Partners and D1 Capital Partners". talent4boards.com.
  8. 1 2 3 "Amy Schulman". www.astp4kt.eu. Retrieved 2024-03-22.
  9. 1 2 3 "Amy Schulman Weds a Lawyer". The New York Times. 1987-08-17. ISSN   0362-4331 . Retrieved 2024-06-04.
  10. ↑ "Trustees Emeriti, Board of Trustees - Wesleyan University". www.wesleyan.edu. Retrieved 2024-03-22.
  11. 1 2 "Ex-Pfizer exec Schulman lands at Polaris after an abrupt departure". fiercebiotech.com.
  12. ↑ "About | Polaris Partners" . Retrieved 2024-06-04.
  13. ↑ "Polaris Innovation Fund | Polaris Partners" . Retrieved 2024-06-04.
  14. ↑ Fractyl. "Amy Schulman". Fractyl. Retrieved 2024-06-04.
  15. ↑ "Amy Schulman - Director at ByHeart". THE ORG. Retrieved 2024-06-04.
  16. ↑ Fishburn, C Simone. "Amy Schulman on the draw of Singapore, and more – The BioCentury Show". BioCentury. Retrieved 2024-06-04.
  17. ↑ "Amy Schulman". Cardurion. Retrieved 2024-03-22.
  18. ↑ "Amy Schulman, tapped to lead a new Pfizer division, makes an abrupt exit". fiercepharma.com.
  19. ↑ "Leadership in Law: Amy Schulman at DLA Piper - Case - Faculty & Research - Harvard Business School". www.hbs.edu. Retrieved 2024-03-22.
  20. ↑ "Pfizer's Amy Schulman on What Women Need to Succeed in their Careers". Knowledge at Wharton. Retrieved 2024-03-22.
  21. ↑ "Board of Directors". Action Against Hunger. Retrieved 2024-06-04.
  22. ↑ "Previous Margaret Brent Women Lawyers of Achievement Award Recipients".
  23. ↑ "What if we stopped trying to change the people, and we changed the pill instead?". TEDMED. Retrieved 2024-06-04.
  24. ↑ "Ms. Schulman to Wed David Nachman". The New York Times. 1987-04-19. ISSN   0362-4331 . Retrieved 2024-06-04.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.